Semaglutide Weight Loss Dosage Chart: What Does 10 mg Mean?

There is no 10 mg dose on an FDA-approved semaglutide weight loss dosage chart. Wegovy, the brand of semaglutide approved for chronic weight management in the United States, tops out at 2.4 mg injected once a week. When people search for a "semaglutide weight loss dosage chart 10mg," they are usually looking at tirzepatide dosing, a compounded vial concentration, or an oral tablet strength.

The Actual Semaglutide Weight Loss Dosage Chart in Milligrams

Wegovy follows a fixed escalation schedule with four weeks at each step. A prescriber only moves you up if you are tolerating the current dose.

Weeks	Weekly dose	Purpose of the step
1–4	0.25 mg	Starting dose to build tolerance
5–8	0.5 mg	First increase
9–12	1 mg	Mid-range dose
13–16	1.7 mg	Step toward maintenance
17 and beyond	2.4 mg	Target maintenance dose

The 2.4 mg weekly dose is the target maintenance dose, not a starting point. Most patients stay at 2.4 mg long term unless side effects require stepping down.

Researchers have also studied higher experimental doses. The STEP UP trial tested semaglutide 7.2 mg and reported roughly 20% average weight loss, but 7.2 mg is not FDA-approved, and 10 mg does not appear anywhere on an approved semaglutide schedule.

Where the "10 mg" Number Comes From

Confusion about a 10 mg semaglutide dose is common, and it usually traces back to one of three sources.

• Tirzepatide. The 10 mg step is a real milestone on a tirzepatide dosage chart for weight loss, which is one reason the two medications get mixed up.
• Compounded vials. A bottle labeled "10 mg/mL" describes concentration, not the amount you inject. A 2.4 mg dose drawn from a 10 mg/mL vial is only 0.24 mL of liquid.
• Oral tablets. Oral semaglutide is dosed in milligrams per day, and those numbers are much larger than the injectable ones.

Oral Semaglutide and Tablets

Rybelsus is oral semaglutide approved for type 2 diabetes, not for weight loss. It is taken as 3 mg daily for 30 days, then 7 mg, and sometimes 14 mg. Oral products follow a completely different schedule, so the semaglutide tablet dose for weight loss is not something an injectable chart can answer.

A daily oral semaglutide product for weight loss has been studied at 25 mg and 50 mg, but those are separate formulations with separate labeling from the injectable. If you see a number like 14 mg or 25 mg, you are probably reading an oral schedule rather than an injection schedule.

Reading a Semaglutide Weight Loss Dosage Chart in Units

Compounded semaglutide is often drawn into a U-100 insulin syringe, where 100 units equals 1 mL. That means the same milligram dose converts to a different number of units depending on the vial's concentration.

Vial concentration	0.25 mg	0.5 mg	1 mg	1.7 mg	2.4 mg
2.5 mg/mL	10 units	20 units	40 units	68 units	96 units
5 mg/mL	5 units	10 units	20 units	34 units	48 units
10 mg/mL	2.5 units	5 units	10 units	17 units	24 units

Always confirm the concentration printed on your vial before converting. A semaglutide weight loss dosage chart units table written for one concentration can lead you to draw the wrong amount from a different vial.

Why the Dose Increases Over Time

Semaglutide mimics a gut hormone called GLP-1 that signals fullness to the brain and slows stomach emptying. The body adapts to the starting dose within a few weeks, so appetite suppression tends to fade.

Understanding why increase dose of semaglutide for weight loss happens comes down to that tolerance curve. Raising the dose restores the effect, but it also raises the risk of nausea, vomiting, and constipation, which is why the steps are small and spaced four weeks apart.

Semaglutide vs Tirzepatide Weight Loss

Both drugs are injectable GLP-1 medications, but tirzepatide also acts on GIP, a second hormone. Head-to-head data on semaglutide vs tirzepatide weight loss shows tirzepatide tends to produce somewhat greater average weight loss at its highest doses.

Feature	Semaglutide (Wegovy)	Tirzepatide (Zepbound)
Maximum approved weekly dose	2.4 mg	15 mg
Typical titration length	About 16 weeks	About 20 weeks
Average weight loss in trials	About 15%	About 20–21%
Dosing frequency	Once weekly	Once weekly
Includes a 10 mg step	No	Yes

Neither drug is a cure, and individual results vary widely. Some people lose about 5% of their body weight; others lose more than 20%.

Safety and What to Ask Your Prescriber

Semaglutide is not appropriate for everyone. People with a personal or family history of medullary thyroid cancer, MEN2 syndrome, pancreatitis, or severe gastroparesis should discuss risks with a clinician before starting.

Before you accept any dose, ask three questions:

1. What is the exact milligram dose printed on my label?
2. What concentration is this vial, and how many units does that equal?
3. Which side effects mean I should call you instead of pushing through?

Pregnancy, breastfeeding, and certain medications require extra caution. This article is informational and does not replace personalized medical advice.

COMMON QUESTIONS

Frequently Asked Questions

Is there a 10 mg semaglutide dose for weight loss?

No. The highest FDA-approved weekly dose of semaglutide for weight management is 2.4 mg, sold as Wegovy. A 10 mg step belongs to tirzepatide (Zepbound), which is a different drug. If a chart shows 10 mg of semaglutide, it is likely a vial concentration or a labeling error.

How many units is 0.5 mg of semaglutide?

It depends entirely on the concentration of the vial. At 5 mg/mL, 0.5 mg equals 10 units; at 2.5 mg/mL it equals 20 units; and at 10 mg/mL it equals 5 units. Check the label every time before you draw a dose.

Can I switch between semaglutide and tirzepatide on my own?

No. The dose steps do not convert directly, so a 10 mg tirzepatide dose has no matching semaglutide dose. Most clinicians restart at a lower step when switching drugs. Doing it without supervision raises the risk of severe gastrointestinal side effects.